Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Coronavirus disease - COVID-19
| Delgocitinib | 050 1件: 50 💬1. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Coronavirus disease - COVID-19
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬2. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Coronavirus disease - COVID-19
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬3. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Coronavirus disease - COVID-19
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬4. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Coronavirus disease - COVID-19
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬4. Coronavirus disease - COVID-19
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Coronavirus disease - COVID-19 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Coronavirus disease - COVID-19
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Epstein-Barr virus infection
| Delgocitinib | 050 1件: 50 💬7. Epstein-Barr virus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Epstein-Barr virus infection
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬8. Epstein-Barr virus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Epstein-Barr virus infection
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬9. Epstein-Barr virus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Epstein-Barr virus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬10. Epstein-Barr virus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Epstein-Barr virus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬10. Epstein-Barr virus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Epstein-Barr virus infection
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Hepatitis B
| Delgocitinib | 050 1件: 50 💬13. Hepatitis B
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Hepatitis B
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬14. Hepatitis B
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Hepatitis B
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬15. Hepatitis B
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Hepatitis B
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬16. Hepatitis B
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Hepatitis B
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬16. Hepatitis B
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Hepatitis B
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Hepatitis C
| Delgocitinib | 050 1件: 50 💬19. Hepatitis C
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Hepatitis C
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬20. Hepatitis C
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Hepatitis C
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬21. Hepatitis C
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Hepatitis C
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬22. Hepatitis C
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Hepatitis C
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬22. Hepatitis C
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Hepatitis C 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Hepatitis C
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Herpes simplex virus 1 infection
| Delgocitinib | 050 1件: 50 💬25. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Herpes simplex virus 1 infection
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬26. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Herpes simplex virus 1 infection
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬27. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Herpes simplex virus 1 infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬28. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Herpes simplex virus 1 infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬28. Herpes simplex virus 1 infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Herpes simplex virus 1 infection
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Human papillomavirus infection
| Delgocitinib | 050 1件: 50 💬31. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Human papillomavirus infection
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬32. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Human papillomavirus infection
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬33. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Human papillomavirus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬34. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Human papillomavirus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬34. Human papillomavirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Human papillomavirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Human papillomavirus infection
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Influenza A
| Delgocitinib | 050 1件: 50 💬37. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Influenza A
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬38. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Influenza A
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬39. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Influenza A
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬40. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Influenza A
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬40. Influenza A
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Influenza A
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬JAK-STAT signaling pathway
| Delgocitinib | 050 1件: 50 💬43. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬JAK-STAT signaling pathway
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬44. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬JAK-STAT signaling pathway
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬45. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬JAK-STAT signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬46. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬JAK-STAT signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬46. JAK-STAT signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | JAK-STAT signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬JAK-STAT signaling pathway
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Delgocitinib | 050 1件: 50 💬49. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬50. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Kaposi sarcoma-associated herpesvirus infection
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬51. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Kaposi sarcoma-associated herpesvirus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬52. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬52. Kaposi sarcoma-associated herpesvirus infection
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Measles
| Delgocitinib | 050 1件: 50 💬55. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Measles
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬56. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Measles
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬57. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Measles
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬58. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Measles
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬58. Measles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Measles 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Measles
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Necroptosis
| Delgocitinib | 050 1件: 50 💬61. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Necroptosis
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬62. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Necroptosis
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬63. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Necroptosis
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬64. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Necroptosis
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬64. Necroptosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Necroptosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Necroptosis
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬NOD-like receptor signaling pathway
| Delgocitinib | 050 1件: 50 💬67. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬NOD-like receptor signaling pathway
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬68. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬NOD-like receptor signaling pathway
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬69. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬NOD-like receptor signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬70. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬NOD-like receptor signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬70. NOD-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬NOD-like receptor signaling pathway
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Osteoclast differentiation
| Delgocitinib | 050 1件: 50 💬73. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Osteoclast differentiation
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬74. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Osteoclast differentiation
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬75. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Osteoclast differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬76. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Osteoclast differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬76. Osteoclast differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Osteoclast differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Osteoclast differentiation
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Th1 and Th2 cell differentiation
| Delgocitinib | 050 1件: 50 💬79. Th1 and Th2 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Th1 and Th2 cell differentiation
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬80. Th1 and Th2 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Th1 and Th2 cell differentiation
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬81. Th1 and Th2 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Th1 and Th2 cell differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬82. Th1 and Th2 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Th1 and Th2 cell differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬82. Th1 and Th2 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Th1 and Th2 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Th1 and Th2 cell differentiation
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Th17 cell differentiation
| Delgocitinib | 050 1件: 50 💬85. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Th17 cell differentiation
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬86. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Th17 cell differentiation
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬87. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Th17 cell differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬88. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Th17 cell differentiation
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬88. Th17 cell differentiation
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Th17 cell differentiation 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Th17 cell differentiation
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Toll-like receptor signaling pathway
| Delgocitinib | 050 1件: 50 💬91. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Toll-like receptor signaling pathway
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬92. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Toll-like receptor signaling pathway
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬93. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Toll-like receptor signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬94. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Toll-like receptor signaling pathway
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬94. Toll-like receptor signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Toll-like receptor signaling pathway
| Zasocitinib | 096 2件: 96, 97 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Delgocitinib Delgocitinib 💬Toxoplasmosis
| Delgocitinib | 050 1件: 50 💬97. Toxoplasmosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Deucravacitinib Deucravacitinib 💬Toxoplasmosis
| Deucravacitinib | 036 9件: 36, 37, 49, 53, 84, 96, 97, 160, 269 💬98. Toxoplasmosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Filgotinib maleate Filgotinib maleate 💬Toxoplasmosis
| Filgotinib | 046 10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬99. Toxoplasmosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib citrate Tofacitinib citrate 💬Toxoplasmosis
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬100. Toxoplasmosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Tofacitinib Tofacitinib 💬Toxoplasmosis
| Tofacitinib | 002 22件: 2 , 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬100. Toxoplasmosis
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Toxoplasmosis 💬 1 gene, 5 drugs (DrugBank) and 29 diseases |
TYK2 1件: TYK2 💬Coronavirus disease - COVID-19
|
Zasocitinib Zasocitinib 💬Toxoplasmosis
| Zasocitinib | 096 2件: 96, 97 💬
|
Coronavirus disease - COVID-19
1 gene, 5 drugs (DrugBank) and 29 diseases
Epstein-Barr virus infection
1 gene, 5 drugs (DrugBank) and 29 diseases
Hepatitis B
1 gene, 5 drugs (DrugBank) and 29 diseases
Hepatitis C
1 gene, 5 drugs (DrugBank) and 29 diseases
Herpes simplex virus 1 infection
1 gene, 5 drugs (DrugBank) and 29 diseases
Human papillomavirus infection
1 gene, 5 drugs (DrugBank) and 29 diseases
Influenza A
1 gene, 5 drugs (DrugBank) and 29 diseases
JAK-STAT signaling pathway
1 gene, 5 drugs (DrugBank) and 29 diseases
Kaposi sarcoma-associated herpesvirus infection
1 gene, 5 drugs (DrugBank) and 29 diseases
Measles
1 gene, 5 drugs (DrugBank) and 29 diseases
Necroptosis
1 gene, 5 drugs (DrugBank) and 29 diseases
NOD-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 29 diseases
Osteoclast differentiation
1 gene, 5 drugs (DrugBank) and 29 diseases
Th1 and Th2 cell differentiation
1 gene, 5 drugs (DrugBank) and 29 diseases
Th17 cell differentiation
1 gene, 5 drugs (DrugBank) and 29 diseases
Toll-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 29 diseases
Toxoplasmosis
1 gene, 5 drugs (DrugBank) and 29 diseases